Targeted Temperature Management Inc. is developing a new targeted temperature management system to improve outcomes for millions suffering from sudden cardiac arrest and stroke. Their system will provide fast cooling, be minimally invasive, portable, and easy to use without extensive training. It aims to address the large market of $7.3 billion for therapeutic hypothermia treatment in hospitals and ambulances by offering a patented technology superior to current solutions. The company requests $1 million in funding for research and development and regulatory approval activities.

1. Targeted Temperature
Management Inc.

2. New Targeted Temperature
Management Systems will improve
outcomes of millions of patients
suffering from sudden cardiac
arrests and strokes
Targeted Temperature Management Inc.

3. Problem worth solving
17 million people worldwide die from
sudden cardiac arrest and stroke. Many of
them can be saved with total body cooling.
Current Therapeutic Hypothermia systems
are inherently ineffective. TTM Inc. is
developing new Therapeutic Hypothermia
system.
Targeted Temperature Management Inc.

4. Our solutions
 Provide fast rate of cooling
 Minimally invasive
 Allow easy access to the patient
 Portable and usable in ambulances
 Easy to operate without lengthy training
Targeted Temperature Management Inc.

5. Target market
275K
prospects
Market size:
Targeted Temperature Management Inc.
Ambulance vehicles
Hospitals
$7.3B

6. Competitive landscape
Competitors How our solution is better
Philips Healthcare Patented Technology
ZOLL Medical Corp Patented Technology
BeneChill Patented Technology
Cincinnati Sub-Zero Patented Technology
Gaymar Patented Technology
Targeted Temperature Management Inc.

7. Funding needed
$1,000,000 needed for R&D and
attaining regulatory approvals.
Targeted Temperature Management Inc.
$1M

8. Sales channels
Our indirect distribution channels will be
highly qualified in both selling and
servicing our medical devices. These
distribution channels will be carefully
selected for ensuring maximization of
market share and brand equity.
Targeted Temperature Management Inc.

9. Marketing activities
Clinical evidence supported direct,
personal, and word-of-mouth marketing
strategies will create an effective
integrated marketing communications mix
for communicating our value proposition
to potential distribution partners and
consumers.
Targeted Temperature Management Inc.

10. Financial projections
Targeted Temperature Management Inc.

11. Milestones
Date Milestone
November 1, 2014 Gain Funding for Animal Study
February 1, 2015 Complete Animal Study
March 1, 2015 Submit Animal Study Results for Publication
November 1, 2015 Design & Build Clinical Prototype
January 1, 2016 FDA Approval to Conduct a Human Study
Targeted Temperature Management Inc.

12. Team and key roles
Sergey Shushunov
Inventor, Founder, & CEO
Targeted Temperature Management Inc.

13. Partners and resources
Patent for T.T.M.S.
T.T.M.S. is a new Targeted
Temperature Management
System based on hyper cold air
mechanical ventilation. Patent
filed December 3, 2013.
Targeted Temperature Management Inc.